Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Craig Nelson

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Aging & Mental Health|December 7, 2019
The relationship of frailty and disability with suicidal ideation in late life depressionDavid Bickford, Ruth T Morin, Cara Woodworth, et al.
Journal of Affective Disorders|April 29, 2014
Effect of symptom severity on efficacy and safety of aripiprazole adjunctive to antidepressant monotherapy in major depressive disorder: a pooled analysisThomas D Stewart, Ainslie Hatch, Kimberly Largay, et al.
The Primary Care Companion for CNS Disorders|June 1, 2013
Assessment of falls in older patients treated with duloxetine: a secondary analysis of a 24-week randomized, placebo-controlled trialJ Craig Nelson, Tina M M Oakes, Peng Liu, et al.
Journal of Affective Disorders|August 7, 2009
Effects of aripiprazole adjunctive to standard antidepressant treatment on the core symptoms of depression: a post-hoc, pooled analysis of two large, placebo-controlled studiesJ Craig Nelson, Raymond Mankoski, Ross A Baker, et al.
Psychotherapy and Psychosomatics|January 26, 2016
A Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy for Treatment-Resistant DepressionStuart J Eisendrath, Erin Gillung, Kevin L Delucchi, et al.
The Journal of Clinical Psychiatry|July 20, 2006
Extended-release bupropion for patients with major depressive disorder presenting with symptoms of reduced energy, pleasure, and interest: findings from a randomized, double-blind, placebo-controlled studyJames W Jefferson, A John Rush, J Craig Nelson, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 1, 2014
Association of age at depression onset with cognitive functioning in individuals with late-life depression and executive dysfunctionR Scott Mackin, J Craig Nelson, Kevin L Delucchi, et al.
International Journal of Geriatric Psychiatry|July 13, 2022
Cognitive outcomes are differentially associated with depression severity trajectories during psychotherapy treatment for late life major depressive disorderMichelle T Kassel, Emma Rhodes, Philip S Insel, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|January 1, 2014
Cognitive outcomes after psychotherapeutic interventions for major depression in older adults with executive dysfunctionR Scott Mackin, J Craig Nelson, Kevin Delucchi, et al.
The Journal of Clinical Psychiatry|July 21, 2021
Treatment Response With Esketamine Nasal Spray Plus an Oral Antidepressant in Patients With Treatment-Resistant Depression Without Evidence of Early Response: A Pooled Post Hoc Analysis of the TRANSFORM StudiesIbrahim Turkoz, Ella Daly, Jaskaran Singh, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Aging & Mental Health|December 7, 2019
The relationship of frailty and disability with suicidal ideation in late life depressionDavid Bickford, Ruth T Morin, Cara Woodworth, et al.
Journal of Affective Disorders|April 29, 2014
Effect of symptom severity on efficacy and safety of aripiprazole adjunctive to antidepressant monotherapy in major depressive disorder: a pooled analysisThomas D Stewart, Ainslie Hatch, Kimberly Largay, et al.
The Primary Care Companion for CNS Disorders|June 1, 2013
Assessment of falls in older patients treated with duloxetine: a secondary analysis of a 24-week randomized, placebo-controlled trialJ Craig Nelson, Tina M M Oakes, Peng Liu, et al.
Journal of Affective Disorders|August 7, 2009
Effects of aripiprazole adjunctive to standard antidepressant treatment on the core symptoms of depression: a post-hoc, pooled analysis of two large, placebo-controlled studiesJ Craig Nelson, Raymond Mankoski, Ross A Baker, et al.
Psychotherapy and Psychosomatics|January 26, 2016
A Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy for Treatment-Resistant DepressionStuart J Eisendrath, Erin Gillung, Kevin L Delucchi, et al.
The Journal of Clinical Psychiatry|July 20, 2006
Extended-release bupropion for patients with major depressive disorder presenting with symptoms of reduced energy, pleasure, and interest: findings from a randomized, double-blind, placebo-controlled studyJames W Jefferson, A John Rush, J Craig Nelson, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 1, 2014
Association of age at depression onset with cognitive functioning in individuals with late-life depression and executive dysfunctionR Scott Mackin, J Craig Nelson, Kevin L Delucchi, et al.
International Journal of Geriatric Psychiatry|July 13, 2022
Cognitive outcomes are differentially associated with depression severity trajectories during psychotherapy treatment for late life major depressive disorderMichelle T Kassel, Emma Rhodes, Philip S Insel, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|January 1, 2014
Cognitive outcomes after psychotherapeutic interventions for major depression in older adults with executive dysfunctionR Scott Mackin, J Craig Nelson, Kevin Delucchi, et al.
The Journal of Clinical Psychiatry|July 21, 2021
Treatment Response With Esketamine Nasal Spray Plus an Oral Antidepressant in Patients With Treatment-Resistant Depression Without Evidence of Early Response: A Pooled Post Hoc Analysis of the TRANSFORM StudiesIbrahim Turkoz, Ella Daly, Jaskaran Singh, et al.
Pageof 9